Adaptive Radiation Treatment for Head and Neck Cancer

NCT01504815 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

268

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Cancer

Interventions

DRUG: cisplatinum
RADIATION: Conventional radiotherapy
RADIATION: Adaptive radiotherapy

Sponsor

The Netherlands Cancer Institute

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]